# Molecular Partners (MOLN) — Earnings

MOLN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/moln/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.43 |
| EPS estimate | −$0.44 |
| EPS surprise | +1.72% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 25, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1745114/000174511426000028/moln-20260630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 25, 2026 | −$0.44 | −$0.43 | 1.72% | — | — |
| Q4 2025 | Mar 12, 2026 | −$0.43 | −$0.43 | -2.19% | — | — |
| Q3 2025 | Oct 30, 2025 | −$0.40 | −$0.40 | -0.78% | — | — |
| Q2 2025 | Aug 25, 2025 | −$0.47 | −$0.69 | -44.72% | — | — |
| Q1 2025 | May 15, 2025 | −$0.42 | −$0.54 | -28.60% | — | — |
| Q4 2024 | Mar 6, 2025 | −$0.45 | −$0.36 | 18.88% | — | — |
| Q3 2024 | Invalid Date | −$0.63 | −$0.56 | 10.48% | $415,307.00 | $804,182.00 |
| Q2 2024 | Aug 26, 2024 | $0.00 | −$0.52 | 0.00% | — | $1.8M |

## Frequently Asked Questions

### When did Molecular Partners (MOLN) last report earnings?

Molecular Partners last reported on Aug 25, 2026, covering fiscal Q2 2026.

### Did MOLN beat earnings estimates?

Yes. Molecular Partners reported EPS of −$0.43 for Q2 2026 against a −$0.44 estimate — a 1.72% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).